USFDA Approved Biosimilars


The European regulatory authorities led with a specially adapted approval procedure to authorize subsequent versions of previously approved Biologics, termed "similar biological medicinal products", or Biosimilars. This procedure is based on a thorough demonstration of "comparability" of the "similar" product to an existing approved product. In the United States, the Food and Drug Administration (FDA) held that new legislation was required to enable them to approve Biosimilars to those Biologics originally approved through the PHS Act pathway. The FDA gained the authority to approve Biosimilars (including interchangeable that are substitutable with their reference product) as part of the Patient Protection and Affordable Care Act signed by President Obama on March 23, 2010.


    Related Conference of USFDA Approved Biosimilars

    October 31-01, 2024

    37th World Congress on Pharmacology

    Amsterdam, Netherlands
    November 26-27, 2024

    3rd World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland
    November 26-27, 2024

    3rd World Congress on Precision and Personalized Medicine

    Zurich, Switzerland
    November 28-29, 2024

    12th International Conference on Clinical Trials

    Vancouver, Canada
    November 28-29, 2024

    39th World Congress on Pharmacology and Therapeutics

    Paris, France
    December 05-06, 2024

    17th World Drug Delivery Summit

    Dubai, UAE
    February 24-25, 2025

    2nd International Conference on Pharmacognosy

    Madrid, Spain
    March 10-11, 2025

    35th Annual European Pharma Congress

    Rome, Italy
    March 13-14, 2025

    8th International on Pharmacy and Pharmaceutical Conference

    Prague, Czech Republic
    April 14-15, 2025

    18th European Biosimilars Congress

    Paris, France
    June 16-17, 2025

    3rd Global Online Summit on Nanoscience and Nanotechnology

    Zurich, Switzerland
    July 24-25, 2025

    5th World Congress on Cardiovascular Medicine Pharmacology

    Aix-en-Provence, France
    September 23-24, 2025

    10th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    October 22-23, 2025

    7th European Conference on Advance Clinical Trials and Research

    Aix-en-Provence, France

    USFDA Approved Biosimilars Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in